541 related articles for article (PubMed ID: 23178486)
1. STK38 is a critical upstream regulator of MYC's oncogenic activity in human B-cell lymphoma.
Bisikirska BC; Adam SJ; Alvarez MJ; Rajbhandari P; Cox R; Lefebvre C; Wang K; Rieckhof GE; Felsher DW; Califano A
Oncogene; 2013 Nov; 32(45):5283-91. PubMed ID: 23178486
[TBL] [Abstract][Full Text] [Related]
2. Aurora kinases A and B are up-regulated by Myc and are essential for maintenance of the malignant state.
den Hollander J; Rimpi S; Doherty JR; Rudelius M; Buck A; Hoellein A; Kremer M; Graf N; Scheerer M; Hall MA; Goga A; von Bubnoff N; Duyster J; Peschel C; Cleveland JL; Nilsson JA; Keller U
Blood; 2010 Sep; 116(9):1498-505. PubMed ID: 20519624
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation of p53 serine 18 upregulates apoptosis to suppress Myc-induced tumorigenesis.
Sluss HK; Gannon H; Coles AH; Shen Q; Eischen CM; Jones SN
Mol Cancer Res; 2010 Feb; 8(2):216-22. PubMed ID: 20145032
[TBL] [Abstract][Full Text] [Related]
4. IBTK contributes to B-cell lymphomagenesis in Eμ-myc transgenic mice conferring resistance to apoptosis.
Vecchio E; Golino G; Pisano A; Albano F; Falcone C; Ceglia S; Iaccino E; Mimmi S; Fiume G; Giurato G; Britti D; Scala G; Quinto I
Cell Death Dis; 2019 Apr; 10(4):320. PubMed ID: 30975981
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial clearance by the STK38 kinase supports oncogenic Ras-induced cell transformation.
Bettoun A; Joffre C; Zago G; Surdez D; Vallerand D; Gundogdu R; Sharif AA; Gomez M; Cascone I; Meunier B; White MA; Codogno P; Parrini MC; Camonis JH; Hergovich A
Oncotarget; 2016 Jul; 7(28):44142-44160. PubMed ID: 27283898
[TBL] [Abstract][Full Text] [Related]
6. MYC's Fine Line Between B Cell Development and Malignancy.
de Barrios O; Meler A; Parra M
Cells; 2020 Feb; 9(2):. PubMed ID: 32102485
[TBL] [Abstract][Full Text] [Related]
7. The direct Myc target Pim3 cooperates with other Pim kinases in supporting viability of Myc-induced B-cell lymphomas.
Forshell LP; Li Y; Forshell TZ; Rudelius M; Nilsson L; Keller U; Nilsson J
Oncotarget; 2011 Jun; 2(6):448-60. PubMed ID: 21646687
[TBL] [Abstract][Full Text] [Related]
8. Telomerase regulates MYC-driven oncogenesis independent of its reverse transcriptase activity.
Koh CM; Khattar E; Leow SC; Liu CY; Muller J; Ang WX; Li Y; Franzoso G; Li S; Guccione E; Tergaonkar V
J Clin Invest; 2015 May; 125(5):2109-22. PubMed ID: 25893605
[TBL] [Abstract][Full Text] [Related]
9. MYC-driven malignant transformation of mature murine B cells requires inhibition of both intrinsic apoptosis and p53 activity.
Högstrand K; Grandien A
Eur J Immunol; 2019 Mar; 49(3):375-385. PubMed ID: 30281155
[TBL] [Abstract][Full Text] [Related]
10. MINCR is a MYC-induced lncRNA able to modulate MYC's transcriptional network in Burkitt lymphoma cells.
Doose G; Haake A; Bernhart SH; López C; Duggimpudi S; Wojciech F; Bergmann AK; Borkhardt A; Burkhardt B; Claviez A; Dimitrova L; Haas S; Hoell JI; Hummel M; Karsch D; Klapper W; Kleo K; Kretzmer H; Kreuz M; Küppers R; Lawerenz C; Lenze D; Loeffler M; Mantovani-Löffler L; Möller P; Ott G; Richter J; Rohde M; Rosenstiel P; Rosenwald A; Schilhabel M; Schneider M; Scholz I; Stilgenbauer S; Stunnenberg HG; Szczepanowski M; Trümper L; Weniger MA; ; Hoffmann S; Siebert R; Iaccarino I
Proc Natl Acad Sci U S A; 2015 Sep; 112(38):E5261-70. PubMed ID: 26351698
[TBL] [Abstract][Full Text] [Related]
11. Pim1 promotes human prostate cancer cell tumorigenicity and c-MYC transcriptional activity.
Kim J; Roh M; Abdulkadir SA
BMC Cancer; 2010 Jun; 10():248. PubMed ID: 20515470
[TBL] [Abstract][Full Text] [Related]
12. Induction of ectopic Myc target gene JAG2 augments hypoxic growth and tumorigenesis in a human B-cell model.
Yustein JT; Liu YC; Gao P; Jie C; Le A; Vuica-Ross M; Chng WJ; Eberhart CG; Bergsagel PL; Dang CV
Proc Natl Acad Sci U S A; 2010 Feb; 107(8):3534-9. PubMed ID: 20133585
[TBL] [Abstract][Full Text] [Related]
13. The kinases IKBKE and TBK1 regulate MYC-dependent survival pathways through YB-1 in AML and are targets for therapy.
Liu S; Marneth AE; Alexe G; Walker SR; Gandler HI; Ye DQ; Labella K; Mathur R; Toniolo PA; Tillgren M; Gokhale PC; Barbie D; Mullally A; Stegmaier K; Frank DA
Blood Adv; 2018 Dec; 2(23):3428-3442. PubMed ID: 30504235
[TBL] [Abstract][Full Text] [Related]
14. Synergistic effect of Bcl2, Myc and Ccnd1 transforms mouse primary B cells into malignant cells.
Nakagawa M; Tsuzuki S; Honma K; Taguchi O; Seto M
Haematologica; 2011 Sep; 96(9):1318-26. PubMed ID: 21606168
[TBL] [Abstract][Full Text] [Related]
15. The IKK2/NF-{kappa}B pathway suppresses MYC-induced lymphomagenesis.
Klapproth K; Sander S; Marinkovic D; Baumann B; Wirth T
Blood; 2009 Sep; 114(12):2448-58. PubMed ID: 19628709
[TBL] [Abstract][Full Text] [Related]
16. B-cell receptor-driven MALT1 activity regulates MYC signaling in mantle cell lymphoma.
Dai B; Grau M; Juilland M; Klener P; Höring E; Molinsky J; Schimmack G; Aukema SM; Hoster E; Vogt N; Staiger AM; Erdmann T; Xu W; Erdmann K; Dzyuba N; Madle H; Berdel WE; Trneny M; Dreyling M; Jöhrens K; Lenz P; Rosenwald A; Siebert R; Tzankov A; Klapper W; Anagnostopoulos I; Krappmann D; Ott G; Thome M; Lenz G
Blood; 2017 Jan; 129(3):333-346. PubMed ID: 27864294
[TBL] [Abstract][Full Text] [Related]
17. Targeting ornithine decarboxylase in Myc-induced lymphomagenesis prevents tumor formation.
Nilsson JA; Keller UB; Baudino TA; Yang C; Norton S; Old JA; Nilsson LM; Neale G; Kramer DL; Porter CW; Cleveland JL
Cancer Cell; 2005 May; 7(5):433-44. PubMed ID: 15894264
[TBL] [Abstract][Full Text] [Related]
18. Tuberous sclerosis complex is required for tumor maintenance in MYC-driven Burkitt's lymphoma.
Hartleben G; Müller C; Krämer A; Schimmel H; Zidek LM; Dornblut C; Winkler R; Eichwald S; Kortman G; Kosan C; Kluiver J; Petersen I; van den Berg A; Wang ZQ; Calkhoven CF
EMBO J; 2018 Nov; 37(21):. PubMed ID: 30237309
[TBL] [Abstract][Full Text] [Related]
19. CD19 is a major B cell receptor-independent activator of MYC-driven B-lymphomagenesis.
Chung EY; Psathas JN; Yu D; Li Y; Weiss MJ; Thomas-Tikhonenko A
J Clin Invest; 2012 Jun; 122(6):2257-66. PubMed ID: 22546857
[TBL] [Abstract][Full Text] [Related]
20. Suppression of Aurora-A oncogenic potential by c-Myc downregulation.
Yang S; He S; Zhou X; Liu M; Zhu H; Wang Y; Zhang W; Yan S; Quan L; Bai J; Xu N
Exp Mol Med; 2010 Nov; 42(11):759-67. PubMed ID: 20890087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
